Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.
Sign Up to like & getrecommendations! Published in 2023 at "Drugs of today"
DOI: 10.1358/dot.2023.59.3.3419557
Abstract: In recent years, the role of interleukin-17 (IL-17) in orchestrating and manipulating proinflammatory immune responses has received special attention. It has become apparent from murine studies and clinical trials that due to its inhibitory effect… read more here.
Keywords: psoriasis psoriatic; bimekizumab brodalumab; psoriatic arthritis; ixekizumab bimekizumab ... See more keywords